Trial Profile
'A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2014
Price :
$35
*
At a glance
- Drugs Apadenoson (Primary) ; Tc 99m sestamibi
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Sponsors Forest Laboratories
- 03 Jun 2014 New trial record